Marshall Wace, LLP Dynavax Technologies Corp Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $861,619 - $1.01 Million	80,300 New	80,300 $901,000
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $1 Million - $1.15 Million	76,684 Added 87.62%	164,207 $2.3 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $1.11 Million - $1.31 Million	87,523 New	87,523 $1.29 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $4.41 Million - $7.75 Million	444,132 New	444,132 $4.64 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $6.45 Million - $11.1 Million	-866,332 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $140,760 - $208,470	14,437 Added 1.69%	866,332 $9.39 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $56.2 Million - $89.3 Million	-4,264,961 Reduced 83.35%	851,895 $12 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $46.9 Million - $101 Million	5,116,856 New	5,116,856 $98.3 Million
Q2 2021 Aug 13, 2021	SELL	$7.25 - $10.99 $2.51 Million - $3.81 Million	-346,586 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $1.58 Million - $3.87 Million	346,586 New	346,586 $3.41 Million
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $60,038 - $129,782	-16,449 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.08 - $12.09 $80,619 - $137,668	11,387 Added 224.95%	16,449 $120,000
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $598,485 - $976,398	-73,524 Reduced 93.56%	5,062 $46,000
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $931,244 - $1.26 Million	78,586 New	78,586 $974,000

273

129M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.